Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Serum Vitamin D Concentrations and Cognitive Change Over 20 Years: The Atherosclerosis Risk in Communities Neurocognitive Study.

Schneider ALC, Zhao D, Lutsey PL, Gottesman RF, Sharrett AR, Rawlings AM, Alonso A, Knopman D, Mosley TH, Selvin E, Michos ED.

Neuroepidemiology. 2018 Aug 9;51(3-4):131-137. doi: 10.1159/000490912. [Epub ahead of print]

PMID:
30092587
2.

Association of orthostatic hypotension with incident dementia, stroke, and cognitive decline.

Rawlings AM, Juraschek SP, Heiss G, Hughes T, Meyer ML, Selvin E, Sharrett AR, Windham BG, Gottesman RF.

Neurology. 2018 Aug 21;91(8):e759-e768. doi: 10.1212/WNL.0000000000006027. Epub 2018 Jul 25.

PMID:
30045960
3.

Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study.

Lee AK, Rawlings AM, Lee CJ, Gross AL, Huang ES, Sharrett AR, Coresh J, Selvin E.

Diabetologia. 2018 Sep;61(9):1956-1965. doi: 10.1007/s00125-018-4668-1. Epub 2018 Jun 30.

PMID:
29961106
4.

Retinal signs and 20-year cognitive decline in the Atherosclerosis Risk in Communities Study.

Deal JA, Sharrett AR, Rawlings AM, Gottesman RF, Bandeen-Roche K, Albert M, Knopman D, Selvin E, Wasserman BA, Klein B, Klein R.

Neurology. 2018 Mar 27;90(13):e1158-e1166. doi: 10.1212/WNL.0000000000005205. Epub 2018 Feb 28.

PMID:
29490915
5.

Prevalence and correlates of depressive symptoms in older adults across the glycaemic spectrum: the Atherosclerosis Risk in Communities (ARIC) study.

Rawlings AM, Sharrett AR, Golden SH, Windham BG, Selvin E.

Diabet Med. 2018 May;35(5):583-587. doi: 10.1111/dme.13593. Epub 2018 Feb 18.

PMID:
29384594
6.

SES, Heart Failure, and N-terminal Pro-b-type Natriuretic Peptide: The Atherosclerosis Risk in Communities Study.

Vart P, Matsushita K, Rawlings AM, Selvin E, Crews DC, Ndumele CE, Ballantyne CM, Heiss G, Kucharska-Newton A, Szklo M, Coresh J.

Am J Prev Med. 2018 Feb;54(2):229-236. doi: 10.1016/j.amepre.2017.10.014. Epub 2017 Dec 11.

PMID:
29241718
7.

Association of History of Dizziness and Long-term Adverse Outcomes With Early vs Later Orthostatic Hypotension Assessment Times in Middle-aged Adults.

Juraschek SP, Daya N, Rawlings AM, Appel LJ, Miller ER 3rd, Windham BG, Griswold ME, Heiss G, Selvin E.

JAMA Intern Med. 2017 Sep 1;177(9):1316-1323. doi: 10.1001/jamainternmed.2017.2937.

8.

Increases in Biomarkers of Hyperglycemia With Age in the Atherosclerosis Risk in Communities (ARIC) Study.

Warren B, Rawlings AM, Lee AK, Grams M, Coresh J, Selvin E.

Diabetes Care. 2017 Aug;40(8):e96-e97. doi: 10.2337/dc17-0075. Epub 2017 May 15. No abstract available.

9.

Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline.

Rawlings AM, Sharrett AR, Mosley TH, Ballew SH, Deal JA, Selvin E.

Diabetes Care. 2017 Jul;40(7):879-886. doi: 10.2337/dc16-2203. Epub 2017 May 12.

10.

Intracranial atherosclerosis and dementia: The Atherosclerosis Risk in Communities (ARIC) Study.

Dearborn JL, Zhang Y, Qiao Y, Suri MFK, Liu L, Gottesman RF, Rawlings AM, Mosley TH, Alonso A, Knopman DS, Guallar E, Wasserman BA.

Neurology. 2017 Apr 18;88(16):1556-1563. doi: 10.1212/WNL.0000000000003837. Epub 2017 Mar 22.

11.

Multiple imputation of cognitive performance as a repeatedly measured outcome.

Rawlings AM, Sang Y, Sharrett AR, Coresh J, Griswold M, Kucharska-Newton AM, Palta P, Wruck LM, Gross AL, Deal JA, Power MC, Bandeen-Roche KJ.

Eur J Epidemiol. 2017 Jan;32(1):55-66. doi: 10.1007/s10654-016-0197-8. Epub 2016 Sep 12.

12.

Race, APOL1 Risk, and eGFR Decline in the General Population.

Grams ME, Rebholz CM, Chen Y, Rawlings AM, Estrella MM, Selvin E, Appel LJ, Tin A, Coresh J.

J Am Soc Nephrol. 2016 Sep;27(9):2842-50. doi: 10.1681/ASN.2015070763. Epub 2016 Mar 10.

13.

Factor structure of the ARIC-NCS Neuropsychological Battery: An evaluation of invariance across vascular factors and demographic characteristics.

Rawlings AM, Bandeen-Roche K, Gross AL, Gottesman RF, Coker LH, Penman AD, Sharrett AR, Mosley TH.

Psychol Assess. 2016 Dec;28(12):1674-1683. doi: 10.1037/pas0000293. Epub 2016 Mar 10.

14.

Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study.

Lazo M, Halushka MK, Shen L, Maruthur N, Rebholz CM, Rawlings AM, Hoogeveen RC, Brinkley TE, Ballantyne CM, Astor BC, Selvin E.

Am Heart J. 2015 Nov;170(5):961-7. doi: 10.1016/j.ahj.2015.08.008. Epub 2015 Aug 14.

15.

Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.

Selvin E, Rawlings AM, Lutsey PL, Maruthur N, Pankow JS, Steffes M, Coresh J.

Circulation. 2015 Jul 28;132(4):269-77. doi: 10.1161/CIRCULATIONAHA.115.015415. Epub 2015 May 28.

16.

Diabetes in midlife and cognitive change over 20 years: a cohort study.

Rawlings AM, Sharrett AR, Schneider AL, Coresh J, Albert M, Couper D, Griswold M, Gottesman RF, Wagenknecht LE, Windham BG, Selvin E.

Ann Intern Med. 2014 Dec 2;161(11):785-93. doi: 10.7326/M14-0737.

17.

Association of 1,5-anhydroglucitol with diabetes and microvascular conditions.

Selvin E, Rawlings AM, Grams M, Klein R, Steffes M, Coresh J.

Clin Chem. 2014 Nov;60(11):1409-18. doi: 10.1373/clinchem.2014.229427. Epub 2014 Sep 8.

18.

Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.

Selvin E, Rawlings AM, Grams M, Klein R, Sharrett AR, Steffes M, Coresh J.

Lancet Diabetes Endocrinol. 2014 Apr;2(4):279-88. doi: 10.1016/S2213-8587(13)70199-2. Epub 2014 Jan 15.

19.

High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study.

Schneider AL, Rawlings AM, Sharrett AR, Alonso A, Mosley TH, Hoogeveen RC, Ballantyne CM, Gottesman RF, Selvin E.

Eur Heart J. 2014 Jul 14;35(27):1817-24. doi: 10.1093/eurheartj/ehu124. Epub 2014 Mar 30.

20.

Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: the ARIC neurocognitive study.

Gottesman RF, Rawlings AM, Sharrett AR, Albert M, Alonso A, Bandeen-Roche K, Coker LH, Coresh J, Couper DJ, Griswold ME, Heiss G, Knopman DS, Patel MD, Penman AD, Power MC, Selnes OA, Schneider AL, Wagenknecht LE, Windham BG, Wruck LM, Mosley TH.

Am J Epidemiol. 2014 Apr 15;179(8):956-66. doi: 10.1093/aje/kwu020. Epub 2014 Mar 13.

21.

Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the US population.

Foster MC, Rawlings AM, Marrett E, Neff D, Grams ME, Kasiske BL, Willis K, Inker LA, Coresh J, Selvin E.

Am J Kidney Dis. 2014 May;63(5):753-60. doi: 10.1053/j.ajkd.2013.11.014. Epub 2013 Dec 25.

22.

Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States.

Foster MC, Rawlings AM, Marrett E, Neff D, Willis K, Inker LA, Coresh J, Selvin E.

Am Heart J. 2013 Jul;166(1):150-6. doi: 10.1016/j.ahj.2013.03.016. Epub 2013 May 1.

23.

No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes.

Selvin E, Rawlings AM, Bergenstal RM, Coresh J, Brancati FL.

Diabetes Care. 2013 Oct;36(10):2995-3001. doi: 10.2337/dc12-2715. Epub 2013 May 30.

24.

sRAGE and risk of diabetes, cardiovascular disease, and death.

Selvin E, Halushka MK, Rawlings AM, Hoogeveen RC, Ballantyne CM, Coresh J, Astor BC.

Diabetes. 2013 Jun;62(6):2116-21. doi: 10.2337/db12-1528. Epub 2013 Feb 8.

Supplemental Content

Loading ...
Support Center